American Society of Hematology

Fig. 4.

Cytolytic activity of 3 EBV-specific CTL lines against EBV and tumor targets.

Transduced CTLs were tested against ⁵¹Cr-labeled autologous LCLs, class I mismatched allogeneic LCLs, G $_{D 2}^{+}$ neuroblastoma tumor cells (LAN-1), G $_{D 2}^{-}$ rhabdomyosarcoma cells (A-204), or autologous phytohemagglutinin-stimulated lymphoblasts. (A) 14.G2a-ζ– and 14.G2a-Δ–transduced CTL line no. 2, (B) 14.G2a-ζ–transduced CTL line no. 4, (C) 14.G2a-ζ–transduced CTL line no. 8.

This Feature Is Available To Subscribers Only